SYDENHAM Laboratories, Inc.
Caroline Espineli has extensive experience in market research and sales, currently serving as Sales and Marketing Assistant Manager and Market Intelligence Officer at SYDENHAM Laboratories, Inc. since September 2011, where responsibilities include product streaming and preparing job orders. Prior experience includes a role as Senior Market Research Executive at Synovate Inc. from April 2006 to September 2011, where duties encompassed client consultations, research design, fieldwork supervision, data analysis, and report preparation. Caroline Espineli holds a Bachelor of Science in Applied Mathematics with a major in Statistics from Cavite State University and has completed units toward an MBA in Business Administration at De La Salle University, Dasmarinas.
This person is not in any offices
SYDENHAM Laboratories, Inc.
Sydenham Laboratories, Inc. (SLI) is an ISO 9001:2008, HACCP Certified, PIC/s GMP compliant pharmaceutical company that develops and manufactures healthcare products. SLI manufactures oral drug preparations in dosage forms of tablet, capsule, syrup, and powder for suspension. Non-penicillin, penicillin and cephalexin-based products are manufactured in separate buildings with 'clean room hepa-filtered' exclusive air-handling systems to ensure zero-cross contamination. SLI also manufactures food supplements in the above dosage forms. SLI is founded in 1971 by Dr. Eduardo R. dela Cruz, MD, a cardiologist and a former president of Philippine Medical Association. SLI derived its name from one of the great British physicians, Dr. Thomas Sydenham, known as the English Hippocrates, the founder of clinical medicine, and an advocate of effective management of illness that emphasized detailed observation and maintained patient records.